An observational study in Down Syndrome, sponsored by Institut Jerome Lejeune. Completed at 1 site in France. Open to participants aged 8 Years and older. Per ClinicalTrials.gov, last updated 2012-03-22.
Sponsored by Institut Jerome Lejeune · Observational
The purpose of this study is to correlate phenotype and genotype of Down syndrome patients in order to identify the biochemical reactions involved in their mental retardation and their other phenotypic characteristics.
432 studies on the registry are indexed under Down Syndrome; 100 are open to participants now.
This study's enrollment of 524 is above the median of 150 across 141 observational studies indexed under Down Syndrome.
Browse Down Syndrome studies →Institut Jerome Lejeune is the lead sponsor of 10 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Down syndrome patients
Exclusion Criteria:
This study is completed, as verified in Dec 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institut Jerome Lejeune